نتایج جستجو برای: ii bcl2

تعداد نتایج: 584067  

Journal: :Blood 2000
J W Vaandrager E Schuuring K Philippo P M Kluin

Using DNA fiber fluorescence in-situ hybridization (FISH) and 3-color interphase FISH, 2 cases of follicular lymphoma were identified in which the BCL2 gene was excised from 18q21 and inserted into the immunoglobulin heavy chain (IGH) locus at 14q32. Both the insertion breakpoint at 14q32 and the deletion breakpoint at 18q21 were cloned using inverse polymerase chain reaction. Sequence analysis...

Journal: :Molecular medicine reports 2015
Georgios I Karaliotas Konstantinos Mavridis Andreas Scorilas George C Babis

Osteoarthritis (OA) is primarily characterized by articular cartilage degeneration and chondrocyte loss. Although the role of apoptosis in cartilage pathobiology remains to be elucidated, the apoptotic B‑cell CLL/lymphoma 2 (BCL2) gene family is considered to be involved in OA. The purpose of the present study was to quantitatively analyze the mRNA expression profiles of the BCL2‑associated X p...

2012
Takeshi Moriishi Ryo Fukuyama Masako Ito Toshihiro Miyazaki Takafumi Maeno Yosuke Kawai Hisato Komori Toshihisa Komori

Reduced mechanical stress is a major cause of osteoporosis in the elderly, and the osteocyte network, which comprises a communication system through processes and canaliculi throughout bone, is thought to be a mechanosensor and mechanotransduction system; however, the functions of osteocytes are still controversial and remain to be clarified. Unexpectedly, we found that overexpression of BCL2 i...

2015
Alexandra Clipson Sharon Barrans Naiyan Zeng Simon Crouch Nicholas F Grigoropoulos Hongxiang Liu Sylvia Kocialkowski Ming Wang Yuanxue Huang Lisa Worrillow John Goodlad Jenny Buxton Michael Neat Paul Fields Bridget Wilkins John W Grant Penny Wright Hesham EI‐Daly George A Follows Eve Roman A James Watkins Peter W M Johnson Andrew Jack Ming‐Qing Du

A proportion of MYC translocation positive diffuse large B-cell lymphomas (DLBCL) harbour a BCL2 and/or BCL6 translocation, known as double-hit DLBCL, and are clinically aggressive. It is unknown whether there are other genetic abnormalities that cooperate with MYC translocation and form double-hit DLBCL, and whether there is a difference in clinical outcome between the double-hit DLBCL and tho...

2014
Anna Zekavati Asghar Nasir Amor Alcaraz Maceler Aldrovandi Phil Marsh John D. Norton John J. Murphy

The human ZFP36 zinc finger protein family consists of ZFP36, ZFP36L1, and ZFP36L2. These proteins regulate various cellular processes, including cell apoptosis, by binding to adenine uridine rich elements in the 3' untranslated regions of sets of target mRNAs to promote their degradation. The pro-apoptotic and other functions of ZFP36 family members have been implicated in the pathogenesis of ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Mario Giuliano Huizhong Hu Yen-Chao Wang Xiaoyong Fu Agostina Nardone Sabrina Herrera Sufeng Mao Alejandro Contreras Carolina Gutierrez Tao Wang Susan G Hilsenbeck Carmine De Angelis Nicholas J Wang Laura M Heiser Joe W Gray Sara Lopez-Tarruella Anne C Pavlick Meghana V Trivedi Gary C Chamness Jenny C Chang C Kent Osborne Mothaffar F Rimawi Rachel Schiff

PURPOSE To investigate the direct effect and therapeutic consequences of epidermal growth factor receptor 2 (HER2)-targeting therapy on expression of estrogen receptor (ER) and Bcl2 in preclinical models and clinical tumor samples. EXPERIMENTAL DESIGN Archived xenograft tumors from two preclinical models (UACC812 and MCF7/HER2-18) treated with ER and HER2-targeting therapies and also HER2+ cl...

Journal: :Frontiers in bioscience : a journal and virtual library 2006
Aruna Basu Garrett DuBois Subrata Haldar

Apoptosis is a process that can occur normally, such as during tissue remodeling, embryogenesis or abnormally during certain pathologies, such as cancer. The identification of the Bcl2 as well as IAP family members has suggested that excessive inhibition of apoptosis may constitute a common feature of all known human cancers-the ability to influence their onset, progression and outcome. Bcl2 fa...

Journal: :International journal of clinical and experimental pathology 2015
Qi-Xing Gong Ting-Xun Lu Chong Liu Zhen Wang Jin-Hua Liang Wei Xu Jian-Yong Li Zhi-Hong Zhang Qi Chen

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease that great efforts had been made in to build up molecular and immunophenotypic subgroups that could relatively accurate indicate prognosis and give clue to therapy. Recently, CD30 was reported as a useful predictor with favorable clinical outcome. However, CD30 expression patterns and the clinicopathologic features of CD30 positiv...

Journal: :Oncotarget 2016
Qing Ye Zijun Y Xu-Monette Alexandar Tzankov Lijuan Deng Xiaoxiao Wang Ganiraju C Manyam Carlo Visco Santiago Montes-Moreno Li Zhang Karen Dybkær April Chiu Attilio Orazi Youli Zu Govind Bhagat Kristy L Richards Eric D Hsi William W L Choi J Han van Krieken Jooryung Huh Maurilio Ponzoni Andrés J M Ferreri Ben M Parsons Michael B Møller Miguel A Piris Jane N Winter L Jeffrey Medeiros Shimin Hu Ken H Young

Double-hit B-cell lymphoma is a common designation for a group of tumors characterized by concurrent translocations of MYC and BCL2, BCL6, or other genes. The prognosis of concurrent MYC and BCL6 translocations is not well known. In this study, we assessed rearrangements and expression of MYC, BCL2 and BCL6 in 898 patients with de novo diffuse large B-cell lymphoma treated with standard chemoth...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Yeon Hee Park Sang Kyun Sohn Jong Gwang Kim Myung-Hoon Lee Hong Suk Song Min Kyoung Kim Joo Seop Jung Je-Joong Lee Hyeoung Joon Kim Dong Hwan Kim

PURPOSE Rituximab may overcome bcl-2-mediated chemoresistance through the inhibition of interleukin-10 (IL-10)-mediated loops, thus down-regulating bcl-2 expression. We examined the effects of genetic variation in BCL2/IL10 gene loops on treatment outcomes of diffuse large B-cell lymphoma when treated with either CHOP or rituximab plus CHOP (R-CHOP) chemotherapy. EXPERIMENTAL DESIGN Four geno...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید